In vitro Immunological Assays

Session Chair - Not Funded(s)

• KV

  Katie Vowell, PhD

  Team Leader
  GlaxoSmithKline, Pennsylvania, United States

Session Chair(s)

• 

  Catherine Tralau-Stewart, PhD

  Senior Director Alliances
  Takeda Pharmaceuticals, California, United States

Presentations:

• 1:00 PM – 1:30 PM

  The nELISA: a high-throughput proteomic technology enables phenotypic screening of PBMC secretomes
  

  Milad Dagher, PhD – Nomic Bio
• 1:30 PM – 2:00 PM

  Sorting Single T-cells Based on Cytokine Secretion Using 3D Structured Microparticles
  

  Doyeon Koo, n/a – UCLA
• 2:00 PM – 2:30 PM

  To Be Provided
  

  Tullia C. Bruno, PhD – University of Pittsburgh/UPMC Hillman Cancer Center